The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
The Invisible Cancer Podcast raises awareness of neuroendocrine cancer, a cancer most people have never heard of, and this lack of awareness can affect diagnosis, treatment, and care. Through real-life stories, expert insights, and practical advice, we explore the challenges patients face, from initial diagnosis to management, including the impact on mental health and ongoing follow-up.
Hosted by Lisa Walker and produced by Neuroendocrine Cancer UK, this podcast shines a light on neuroendocrine and other often-overlooked cancers, offering information, support, and connection to anyone affected.
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
Liver Transplants for Neuroendocrine Cancer patients
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, Neuroendocrine Cancer UK's CEO, Catherine Bouvier, talks to Dr Tahir Shah about his work in developing a new service for Neuroendocrine Cancer patients to improve outcomes and their quality of life through using surgery and liver transplantation.
Dr Shah is a Consultant Liver Transplant Physician at Queen Elizabeth Hospital Birmingham. He is also Lead Clinician for the Neuroendocrine Tumour [NET] and Hepatocellular Cancer [HCC] Services at Birmingham.
He developed specialist services for Midlands’ Neuroendocrine Tumour patients resulting in the Birmingham NET Service becoming a European Neuroendocrine Tumour Society [ENETS] certified Centre of Excellence. Dr Shah is leading a number of additional service improvement initiatives including: delivery of a national programme of Liver Transplantation for unresectable NET Liver Metastases, creation of a comprehensive service for patients with carcinoid heart disease and standardising initial management of Neuroendocrine Tumours, including lung NETs.
Further support: